Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The Effect of Xiidra on Comfort and Dryness in Symptomatic Contact Lens Wearers

Next Previous
Trial Profile

The Effect of Xiidra on Comfort and Dryness in Symptomatic Contact Lens Wearers

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 31 Oct 2025

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Lifitegrast (Primary)
  • Indications Dry eyes
  • Focus Therapeutic Use
  • Acronyms COLLIE

Most Recent Events

  • 09 Sep 2025 According to a Bausch & Lomb media release, the study was investigator-initiated and independently conducted by CORE at the University of Waterloo, with Bausch + Lomb providing the study medication and support.
  • 09 Sep 2025 Results presented in a Bausch & Lomb media release
  • 09 Sep 2025 Primary endpoint has been met (Difference in contact lens-related dryness at 12 weeks compared to baseline) , according to a Bausch & Lomb media release

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top